|
Variable
|
Post-thrombolysis END
|
Post-thrombolysis ENI
|
|---|
|
OR (95%CI)
|
P
|
OR (95%CI)
|
P
|
|---|
|
Age
|
1.015 (0.997–1.034)
|
0.109
|
0.980 (0.967–0.992)
|
0.002
|
|
Previous antiplatelet
|
0.654 (0.363–1.179)
|
0.158
|
1.249 (0.865–1.804)
|
0.235
|
|
NIHSS
|
1.041 (1.012–1.070)
|
0.005
|
1.029 (0.997–1.055)
|
0.102
|
|
DBP
|
0.997 (0.984–1.011)
|
0.704
|
0.985 (0.974–0.995)
|
0.003
|
|
HT
|
1.637 (0.849–3.157)
|
0.142
|
0.456 (0.229–0.908)
|
0.025
|
|
OTT
|
1.001 (0.998–1.005)
|
0.504
|
0.992 (0.990–0.995)
|
0.001
|
|
PAO
|
1.277 (0.834–1.954)
|
0.260
|
0.688 (0.489–0.968)
|
0.032
|
|
Stroke subtype
|
|
LAA
|
Reference
| |
Reference
| |
|
CE
|
0.988 (0.287–3.402)
|
0.984
|
0.365 (0.123–1.080)
|
0.069
|
|
SAO
|
0.263 (0.114–0.608)
|
0.002
|
0.649 (0.332–1.269)
|
0.206
|
|
SOE
|
0.477 (0.222–1.023)
|
0.057
|
1.229 (0.640–2.360)
|
0.535
|
|
SUE
|
0.410 (0.193–0.872)
|
0.021
|
0.862 (0.454–1.638)
|
0.651
|
|
FBG
|
1.112 (1.038–1.191)
|
0.003
|
1.054 (0.996–1.116)
|
0.070
|
|
Hs-CRP
|
1.036 (1.015–1.057)
|
0.002
|
1.013 (0.995–1.032)
|
0.156
|
|
NLR
|
1.385 (1.238–1.551)
|
0.001
|
0.713 (0.643–0.791)
|
0.001
|
|
PLR
|
1.013 (1.009–1.016)
|
0.001
|
1.005 (0.999–1.011)
|
0.084
|
|
LMR
|
0.680 (0.560–0.825)
|
0.001
|
1.023 (0.889–1.172)
|
0.751
|
- Abbreviations: END early neurological deterioration, ENI early neurological improvement, OR odds ratio, CI confidence interval, NIHSS National Institute of Health Stroke Scale, DBP diastolic blood pressure, HT hemorrhagic transformation, OTT onset to treatment time, PAO proximal arterial occlusion, LAA large-artery atherosclerosis, CE cardioembolism, SAO small-artery occlusion, SOE stroke of other determined etiology, SUE stroke of undetermined etiology, FBG fasting blood glucose, Hs-CRP hyper-sensitive C-reactive protein, NLR neutrophil-lymphocyte ratio, PLR platelet-lymphocyte ratio, LMR lymphocyte-monocyte ratio
